Page last updated: 2024-09-02

desmethylsertraline and Coronary Disease

desmethylsertraline has been researched along with Coronary Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cooper, TB; Glassman, AH; Krishnan, KR; Lekht, V; Malinin, AI; O'Connor, CM; Serebruany, VL; Suckow, RF; van Zyl, LT1
Gurbel, PA; O'Connor, CM; Serebruany, VL1

Other Studies

2 other study(ies) available for desmethylsertraline and Coronary Disease

ArticleYear
Relationship between release of platelet/endothelial biomarkers and plasma levels of sertraline and N-desmethylsertraline in acute coronary syndrome patients receiving SSRI treatment for depression.
    The American journal of psychiatry, 2005, Volume: 162, Issue:6

    Topics: Biomarkers; Blood Platelets; Coronary Disease; Coronary Vessels; Endothelium, Vascular; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline

2005
Platelet inhibition by sertraline and N-desmethylsertraline: a possible missing link between depression, coronary events, and mortality benefits of selective serotonin reuptake inhibitors.
    Pharmacological research, 2001, Volume: 43, Issue:5

    Topics: Coronary Disease; Depression; Flow Cytometry; Humans; In Vitro Techniques; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Receptors, Cell Surface; Selective Serotonin Reuptake Inhibitors; Sertraline

2001